PZ Cussons Full-Year Results Show Revenue Rise as Debt TumblesBy Martin Holloway06/09/2026 PZ Cussons (LON: PZC) released its PZ Cussons full-year results for the year ended 31…
UK Bank Windfall Tax Calls Mount as Big Four Post £29bn in ProfitsBy Martin Holloway06/09/2026 Pressure for a UK bank windfall tax intensified this week after Britain’s four largest lenders…
Anthropic IPO Prospectus Timing Blurs After AMD’s $5bn BetBy Martin Holloway05/09/2026 AMD has committed up to $5bn to Anthropic, but claims the Anthropic IPO prospectus is days away outrun what filings and sourcing actually show.
Wadworth PISCES Auction to Open Asset Match’s Private Market DebutBy Martin Holloway05/09/2026 Wiltshire brewer Wadworth will be the first company to trade through a Wadworth PISCES auction…
Illumina joins S&P 500 as Bloom Energy, Everpure also addedBy Martin Holloway05/09/2026 S&P 500 inclusion for Illumina, Bloom Energy and Everpure takes effect 21 September, replacing Molson Coors, Trade Desk and Builders FirstSource.
LinkedIn Automation Gains Traction Among UK Investing FirmsBy Martin Holloway05/09/2026 LinkedIn automation has moved into the workflow of UK investing firms as professional networks expand…
FIH Group Momart Sale Pushes Shares Up 25% on AIMBy Martin Holloway05/09/2026 The FIH Group Momart sale drove the AIM-listed conglomerate’s shares up 25.6% to 135p on…
The Weekly Close: S&P 500 Barely Moves as Stocks Diverge BeneathBy Martin Holloway05/09/2026 The S&P 500 weekly close was flat at 769.45, but Robinhood, Sandisk and Fair Isaac posted double-digit swings beneath the surface.
Zotefoams H1 2026 Results Show Revenue Up 23% to £95.2mBy Martin Holloway04/09/2026 Zotefoams H1 2026 results, released Wednesday morning, confirmed group revenue rose 23% to £95.2m in…
FDA Approves Ionis’s Zanvastro for Alexander DiseaseBy Martin Holloway04/09/2026 FDA approves Zanvastro, the first Alexander disease treatment, from Ionis Pharmaceuticals – but shares barely move on the news.
